# Liver Stiffness Measurement (LSM) in Predicting Progress of Liver Fibrosis After TACE for Hepatocellular Carcinoma

> **NCT03285867** · — · UNKNOWN · sponsor: **Nanfang Hospital, Southern Medical University** · enrollment: 200 (estimated)

## Conditions studied

- Hepatocellular Carcinoma
- Liver Failure

## Interventions

- **PROCEDURE:** TACE

## Key facts

- **NCT ID:** NCT03285867
- **Lead sponsor:** Nanfang Hospital, Southern Medical University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-06-25
- **Primary completion:** 2021-06
- **Final completion:** 2021-12
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2018-04-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03285867

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03285867, "Liver Stiffness Measurement (LSM) in Predicting Progress of Liver Fibrosis After TACE for Hepatocellular Carcinoma". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03285867. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*